These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26709598)

  • 1. Micro-optical prototyping of a surface acoustic wave-based point-of-care coagulation assay and first application in anticoagulated patients.
    Moll J; Meyer dos Santos S; Hils B; Dornuf F; Meyer dos Santos IR; Singer OC; Ferreirós N; Labocha S; Blücher A; Harder S; Krozer V
    Int J Clin Pharmacol Ther; 2016 Mar; 54(3):177-84. PubMed ID: 26709598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant.
    Mani H; Herth N; Kasper A; Wendt T; Schuettfort G; Weil Y; Pfeilschifter W; Linnemann B; Herrmann E; Lindhoff-Last E
    Ther Drug Monit; 2014 Oct; 36(5):624-31. PubMed ID: 24577124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface Acoustic Wave-Based Microfluidic Coagulation Device for Monitoring Anticoagulant Therapy.
    Harder S; Santos SMD; Krozer V; Moll J
    Semin Thromb Hemost; 2019 Apr; 45(3):253-258. PubMed ID: 30566967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels.
    Hawes EM; Deal AM; Funk-Adcock D; Gosselin R; Jeanneret C; Cook AM; Taylor JM; Whinna HC; Winkler AM; Moll S
    J Thromb Haemost; 2013 Aug; 11(8):1493-502. PubMed ID: 23718677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants.
    Meyer Dos Santos S; Zorn A; Guttenberg Z; Picard-Willems B; Kläffling C; Nelson K; Klinkhardt U; Harder S
    Biomicrofluidics; 2013; 7(5):56502. PubMed ID: 24404078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels.
    Francart SJ; Hawes EM; Deal AM; Adcock DM; Gosselin R; Jeanneret C; Friedman KD; Moll S
    Thromb Haemost; 2014 Jun; 111(6):1133-40. PubMed ID: 24401946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants.
    Schmitz EM; Boonen K; van den Heuvel DJ; van Dongen JL; Schellings MW; Emmen JM; van der Graaf F; Brunsveld L; van de Kerkhof D
    J Thromb Haemost; 2014 Oct; 12(10):1636-46. PubMed ID: 25142183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical judgment when using coagulation tests during direct oral anticoagulant treatment: a concise review.
    Di Minno A; Spadarella G; Prisco D; Franchini M; Lupoli R; Di Minno MN
    Semin Thromb Hemost; 2013 Oct; 39(7):840-6. PubMed ID: 24022805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.
    Callé R; Rochefort GY; Desbuards N; Plag C; Antier D; Ossant F
    Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study.
    Toulon P; Ozier Y; Ankri A; Fléron MH; Leroux G; Samama CM
    Thromb Haemost; 2009 Feb; 101(2):394-401. PubMed ID: 19190827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.
    Van Blerk M; Bailleul E; Chatelain B; Demulder A; Devreese K; Douxfils J; Jochmans K; Mullier F; Wijns W; Soumali MR; Coucke W; Vernelen K; Van de Walle P
    Thromb Haemost; 2015 Jan; 113(1):154-64. PubMed ID: 25231101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban.
    Harenberg J; Marx S; Krämer R; Giese C; Weiss C
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):637-41. PubMed ID: 21986465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
    Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
    Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-Care Assessment of Hemostasis with a Love-Mode Surface Acoustic Wave Sensor.
    Chen X; Wang M; Zhao G
    ACS Sens; 2020 Jan; 5(1):282-291. PubMed ID: 31903758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): relation to FXa-activity and influence of assay modifications.
    Harder S; Parisius J; Picard-Willems B
    Thromb Res; 2008; 123(2):396-403. PubMed ID: 18571698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-electromechanical film bulk acoustic sensor for plasma and whole blood coagulation monitoring.
    Chen D; Song S; Ma J; Zhang Z; Wang P; Liu W; Guo Q
    Biosens Bioelectron; 2017 May; 91():465-471. PubMed ID: 28068607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct oral anticoagulants: new drugs and new concepts.
    Levy JH; Spyropoulos AC; Samama CM; Douketis J
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1333-51. PubMed ID: 25523529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microfluidic anti-Factor Xa assay device for point of care monitoring of anticoagulation therapy.
    Harris LF; Rainey P; Castro-López V; O'Donnell JS; Killard AJ
    Analyst; 2013 Sep; 138(17):4769-76. PubMed ID: 23666610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.